PAiN
06-28-2014, 10:45 PM
http://canadajournal.net/wp-content/uploads/2014/06/Aspirin-may-lower-pancreatic-cancer-risk-Study.jpg
Aspirin may lower pancreatic cancer risk, Study
Aspirin may lower pancreatic cancer risk, Study
Jun 28, 2014
Taking regular low doses of aspirin may lower the risk of contracting pancreatic cancer, according to research conducted at Yale University.
The study, published in the journal Cancer Epidemiology, Biomarkers & Prevention, surveyed data on 362 people with pancreatic cancer and 690 people without the disease.
According to the study, men and women who took low-dose aspirin regularly had 48 percent reduction in their risk for developing pancreatic cancer and protection against pancreatic cancer ranged from 39 percent reduction in risk for those who took low-dose aspirin for six years or less, to 60 percent reduction in risk for those who took it for more than 10 years.
Harvey A. Risch of epidemiology in the Department of Chronic Disease Epidemiology at the Yale School of Public Health, said that older studies of aspirin use have been clouded by the use of [regular- or high-dose] aspirin for pain relief from conditions that themselves might be related to the risk for pancreatic cancer.
Risch added that only recently have people been using low-dose aspirin for long enough times [to prevent cardiovascular disease] that the use might bear on risk of pancreatic cancer development and people who are considering aspirin use to reduce the risk for cardiovascular disease can feel positive that their use might also lower their risk for pancreatic cancer, and quite certainly wouldn’t raise it.
Agencies/Canadajournal
Aspirin may lower pancreatic cancer risk, Study
Aspirin may lower pancreatic cancer risk, Study
Jun 28, 2014
Taking regular low doses of aspirin may lower the risk of contracting pancreatic cancer, according to research conducted at Yale University.
The study, published in the journal Cancer Epidemiology, Biomarkers & Prevention, surveyed data on 362 people with pancreatic cancer and 690 people without the disease.
According to the study, men and women who took low-dose aspirin regularly had 48 percent reduction in their risk for developing pancreatic cancer and protection against pancreatic cancer ranged from 39 percent reduction in risk for those who took low-dose aspirin for six years or less, to 60 percent reduction in risk for those who took it for more than 10 years.
Harvey A. Risch of epidemiology in the Department of Chronic Disease Epidemiology at the Yale School of Public Health, said that older studies of aspirin use have been clouded by the use of [regular- or high-dose] aspirin for pain relief from conditions that themselves might be related to the risk for pancreatic cancer.
Risch added that only recently have people been using low-dose aspirin for long enough times [to prevent cardiovascular disease] that the use might bear on risk of pancreatic cancer development and people who are considering aspirin use to reduce the risk for cardiovascular disease can feel positive that their use might also lower their risk for pancreatic cancer, and quite certainly wouldn’t raise it.
Agencies/Canadajournal